98%
921
2 minutes
20
Purpose: To validate JLK-LVO, a software detecting large vessel occlusion (LVO) on computed tomography angiography (CTA), within a multicenter dataset.
Methods: From 2021 to 2023, we enrolled patients with ischemic stroke who underwent CTA within 24-hour of onset at six university hospitals for validation and calibration datasets and at another university hospital for an independent dataset for testing model calibration. The diagnostic performance was evaluated using area under the curve (AUC), sensitivity, and specificity across the entire study population and specifically in patients with isolated middle cerebral artery (MCA)-M2 occlusion. We calibrated LVO probabilities using logistic regression and by grouping LVO probabilities based on observed frequency.
Results: After excluding 168 patients, 796 remained; the mean (SD) age was 68.9 (13.7) years, and 57.7% were men. LVO was present in 193 (24.3%) of patients, and the median interval from last-known-well to CTA was 5.7 h (IQR 2.5-12.1 h). The software achieved an AUC of 0.944 (95% CI 0.926-0.960), with a sensitivity of 89.6% (84.5-93.6%) and a specificity of 90.4% (87.7-92.6%). In isolated MCA-M2 occlusion, the AUROC was 0.880 (95% CI 0.824-0.921). Due to sparse data between 20 and 60% of LVO probabilities, recategorization into unlikely (0-20% LVO scores), less likely (20-60%), possible (60-90%), and suggestive (90-100%) provided a reliable estimation of LVO compared with mathematical calibration. The category of LVO probabilities was associated with follow-up infarct volumes and functional outcome.
Conclusion: In this multicenter study, we proved the clinical efficacy of the software in detecting LVO on CTA.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892136 | PMC |
http://dx.doi.org/10.1186/s12883-025-04107-6 | DOI Listing |
J Neurointerv Surg
August 2025
Stroke Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Background: Rapid identification of large vessel occlusion (LVO) in acute ischemic stroke (AIS) is essential for reperfusion therapy. Screening tools, including Artificial Intelligence (AI) based algorithms, have been developed to accelerate detection but rely heavily on pre-test LVO prevalence. This study aimed to review LVO prevalence across clinical contexts and analyze its impact on AI-algorithm performance.
View Article and Find Full Text PDFInt J Stroke
August 2025
Clinical Neurology, Udine University Hospital and DMED, University of Udine, Udine (Italy).
Background: High-density lipoprotein cholesterol (HDL-C) is traditionally considered protective in cardiovascular disease, but its role in acute ischemic stroke (AIS) remains unclear, particularly in patients undergoing mechanical thrombectomy (MT). This study aimed to assess the association between HDL-C levels and clinical outcomes in AIS patients treated with MT for anterior circulation large vessel occlusion (LVO).
Methods: We conducted a multicentre, observational, post-hoc analysis of AIS patients treated with MT between January 2016 and March 2023 across three stroke centres.
Eur J Med Res
August 2025
Department of Neurology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Background: Lactate dehydrogenase (LDH), a key glycolytic enzyme released abundantly during cellular injury, has been established as a prognostic biomarker in ischemic stroke. However, the dynamic changes and predictive value of serum LDH during the acute phase in patients with large vessel occlusion acute ischemic stroke (LVO-AIS) remain insufficiently characterized.
Methods: This retrospective cohort study consecutively enrolled 414 LVO-AIS patients who underwent endovascular treatment (EVT) at a comprehensive stroke center between January 2019 and November 2024.
J Stroke Cerebrovasc Dis
October 2025
Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; China National Clinical Research Center for Neurological Diseases, Beijing 100070, China. Electronic address:
Objective: Concerns regarding bleeding risks have limited the use of intravenous thrombolysis in acute ischemic stroke (AIS) patients with renal dysfunction (RD). This study investigated the impact of RD on the efficacy and safety of Tenecteplase (TNK) thrombolysis in AIS patients with large vessel occlusions (LVO) beyond the 4.5 h window.
View Article and Find Full Text PDFEur J Pharmacol
October 2025
National Heart & Lung Institute, Imperial College London, London, UK; Department of Cardiology, Royal Brompton Hospital, London, UK.
Background: While endovascular thrombectomy (EVT) achieves recanalization in acute large vessel occlusion (LVO) stroke, residual or recurrent distal emboli can undermine clinical outcomes. This meta-analysis examines whether adjunctive intra-arterial thrombolysis (IAT) administered post-EVT improves therapeutic efficacy without compromising safety.
Methods: A systematic search of PubMed, Scopus, Cochrane Library, and Web of Science (up to May 25, 2025) was conducted to identify randomized controlled trials (RCTs), comparing adjuvant intra-arterial thrombolysis to EVT alone in patients with large vessel occlusion undergoing successful EVT.